Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer
- PMID: 16098468
- DOI: 10.1016/j.ccr.2005.06.015
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer
Abstract
Germline NF1, c-RET, SDH, and VHL mutations cause familial pheochromocytoma. Pheochromocytomas derive from sympathetic neuronal precursor cells. Many of these cells undergo c-Jun-dependent apoptosis during normal development as NGF becomes limiting. NF1 encodes a GAP for the NGF receptor TrkA, and NF1 mutations promote survival after NGF withdrawal. We found that pheochromocytoma-associated c-RET and VHL mutations lead to increased JunB, which blunts neuronal apoptosis after NGF withdrawal. We also found that the prolyl hydroxylase EglN3 acts downstream of c-Jun and is specifically required among the three EglN family members for apoptosis in this setting. Moreover, EglN3 proapoptotic activity requires SDH activity because EglN3 is feedback inhibited by succinate. These studies suggest that failure of developmental apoptosis plays a role in pheochromocytoma pathogenesis.
Comment in
-
A common pathway for genetic events leading to pheochromocytoma.Cancer Cell. 2005 Aug;8(2):91-3. doi: 10.1016/j.ccr.2005.07.012. Cancer Cell. 2005. PMID: 16098460
Similar articles
-
A common pathway for genetic events leading to pheochromocytoma.Cancer Cell. 2005 Aug;8(2):91-3. doi: 10.1016/j.ccr.2005.07.012. Cancer Cell. 2005. PMID: 16098460
-
Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.Fam Cancer. 2005;4(1):13-6. doi: 10.1007/s10689-004-6128-y. Fam Cancer. 2005. PMID: 15883705 Review.
-
The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.Genes Dev. 2008 Apr 1;22(7):884-93. doi: 10.1101/gad.1648608. Epub 2008 Mar 11. Genes Dev. 2008. PMID: 18334619 Free PMC article.
-
Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.Mol Endocrinol. 2010 Dec;24(12):2382-91. doi: 10.1210/me.2010-0256. Epub 2010 Oct 27. Mol Endocrinol. 2010. PMID: 20980436 Free PMC article.
-
Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx.Fam Cancer. 2005;4(1):17-23. doi: 10.1007/s10689-004-5740-1. Fam Cancer. 2005. PMID: 15883706 Review.
Cited by
-
Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.Endocr Relat Cancer. 2013 Feb 18;20(1):65-78. doi: 10.1530/ERC-12-0267. Print 2013 Feb. Endocr Relat Cancer. 2013. PMID: 23154831 Free PMC article.
-
Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth.Oncogene. 2022 Mar;41(12):1752-1766. doi: 10.1038/s41388-022-02203-2. Epub 2022 Feb 5. Oncogene. 2022. PMID: 35124697 Free PMC article.
-
The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.Trans Am Clin Climatol Assoc. 2017;128:298-307. Trans Am Clin Climatol Assoc. 2017. PMID: 28790514 Free PMC article. Review.
-
Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors.PLoS One. 2017 Nov 8;12(11):e0187206. doi: 10.1371/journal.pone.0187206. eCollection 2017. PLoS One. 2017. PMID: 29117193 Free PMC article.
-
Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application.J Adv Res. 2025 Apr;70:159-186. doi: 10.1016/j.jare.2024.04.016. Epub 2024 Apr 25. J Adv Res. 2025. PMID: 38677545 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous